Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 25.3% in First Half of 2023

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 90.2 million yuan in the first half of 2023, up 25.3% year-on-year.

Meanwhile, the company posted 657.5 million yuan in revenue, up 7% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 902.6 million yuan in total liabilities, with a liability-to-asset ratio of 17.1%.